![Ravi Rao](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Ravi Rao
Director/Board Member at
DBV TECHNOLOGIES
Net worth: - $ as of 2026-05-30
Profile
Dr. Ravi M. Rao is a Chief Medical Officer at Swedish Orphan Biovitrum AB and a Member at The Royal College of Physicians. He is on the Board of Directors at DBV Technologies SA. Dr. Rao was previously employed as a Chief Medical Officer by Aeglea Biotherapeutics, Inc. and a Head-Global Medical Affairs by GlaxoSmithKline Plc. He received his undergraduate degree from the University of Cambridge and a doctorate degree from Imperial College London.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 2026-03-17 | 0 ( -.--% ) | - $ | 2026-05-30 |
Ravi Rao active positions
| Companies | Position | Start |
|---|---|---|
| DBV TECHNOLOGIES | Director/Board Member | 2021-05-18 |
| AUTOLUS THERAPEUTICS PLC | Director/Board Member | 2024-03-31 |
The Royal College of Physicians
 The Royal College of Physicians Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | - |
Sitryx Therapeutics Ltd.
 Sitryx Therapeutics Ltd. BiotechnologyHealth Technology Develop disease-modifying therapeutics for autoimmune and inflammatory disease | Chief Tech/Sci/R&D Officer | 2022-03-31 |
SV Health Investors LLP
 SV Health Investors LLP Investment ManagersFinance SV Health Investors invests in companies located across the Globe. The firm focuses on biotechnology, pharmaceuticals, medical devices & instruments and healthcare services sectors. It provides financing for seed, early, growth stage and buyout capital requirements. | Private Equity Investor | 2022-02-28 |
Former positions of Ravi Rao
| Companies | Position | End |
|---|---|---|
| OXFORD BIOMEDICA PLC | Corporate Officer/Principal | 2023-10-31 |
| SWEDISH ORPHAN BIOVITRUM AB | Chief Tech/Sci/R&D Officer | 2021-12-31 |
| SPYRE THERAPEUTICS, INC. | Chief Tech/Sci/R&D Officer | 2020-08-09 |
| GSK PLC | Chief Tech/Sci/R&D Officer | 2019-09-30 |
Training of Ravi Rao
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
89
1st degree connections
11
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 11 |
|---|---|
SV Health Investors LLP
SV Health Investors LLP Investment ManagersFinance SV Health Investors invests in companies located across the Globe. The firm focuses on biotechnology, pharmaceuticals, medical devices & instruments and healthcare services sectors. It provides financing for seed, early, growth stage and buyout capital requirements. | Finance |
Spyre Therapeutics, Inc.
 Spyre Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biotechnology company | Health Technology |
GSK Plc
 GSK Plc Pharmaceuticals: MajorHealth Technology Develops, manufactures and distributes vaccines and other pharmaceutical products | Health Technology |
Oxford Biomedica Plc
 Oxford Biomedica Plc BiotechnologyHealth Technology Operates as a contract development and manufacturing organization which provides viral vectors to pharmaceutical and biotechnology clients in cell and gene therapy fields | Health Technology |
Imperial College London
 Imperial College London Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Cambridge
 University of Cambridge Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
DBV Technologies SA
 DBV Technologies SA Pharmaceuticals: MajorHealth Technology Operates as a clinical stage biopharmaceutical company that focuses on changing the field of immunotherapy | Health Technology |
The Royal College of Physicians
The Royal College of Physicians Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Swedish Orphan Biovitrum AB
 Swedish Orphan Biovitrum AB Pharmaceuticals: MajorHealth Technology Manufactures and supplies pharmaceuticals and orphan drugs in the areas of hematology, immunology and specialty care | Health Technology |
Autolus Therapeutics Plc
 Autolus Therapeutics Plc Pharmaceuticals: MajorHealth Technology Engages in the development and commercialization of gene therapies | Health Technology |
Sitryx Therapeutics Ltd.
Sitryx Therapeutics Ltd. BiotechnologyHealth Technology Develop disease-modifying therapeutics for autoimmune and inflammatory disease | Health Technology |
- Stock Market
- Insiders
- Ravi Rao
